Showing results (1401-1410 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|July 18, 2012
Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trialYoshikuni Mizuno, Mitsutoshi Yamamoto, Sadako Kuno, et al.Clinical Neuropharmacology|July 24, 2012
The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosisFereshteh Naderi, Seyed Amirhossien Javadi, Mahmmoud Motamedi, et al.Clinical Neuropharmacology|August 15, 1998
The efficacy and use of anticonvulsants in mood disordersR T Dunn, M S Frye, T A Kimbrell, et al.Clinical Neuropharmacology|August 15, 1998
Inbred mouse strains differ in their sensitivity to an antiseizure effect of MK-801S I Deutsch, J Mastropaolo, D G Powell, et al.Clinical Neuropharmacology|September 19, 2012
Relief of intractable posthypoxic myoclonus after administration of agomelatineJesús González de la Aleja, Rosa Ana Saiz-Díaz, Pilar De la PeñaClinical Neuropharmacology|December 1, 1990
Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosisH Jung, M Hurtado, M Sanchez, et al.Clinical Neuropharmacology|September 1, 2012
Treatment with paliperidone in children with behavior disorders previously treated with risperidone: an open-label trialDaniel Martín Fernández-Mayoralas, Alberto Fernández-Jaén, Nuria Muñoz-Jareño, et al.Clinical Neuropharmacology|October 1, 1990
Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeysS Boyce, N M Rupniak, M J Steventon, et al.Clinical Neuropharmacology|April 20, 2004
Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experienceHubert H Fernandez, Martha E Trieschmann, Joseph H FriedmanClinical Neuropharmacology|February 17, 2005
The syndrome of irreversible lithium-effectuated neurotoxicityAdityanjee, Kaizad R Munshi, Anita ThampyPageof 237